Table 2.
# of subjects in each population positive for both anti-HERV K10 Gag & Pol antibodies
| Population | N | # positive (%) |
|---|---|---|
| VBD* |
100 |
0(0) |
| LGLL* |
53 |
0(0) |
| HTLVt* |
74 |
18(24) |
| HTLVm*+ |
16 |
14(88) |
| HTLVn*+ |
58 |
4(7) |
| MS*+ | 83 | 4(5) |
*p = 1.000, < 0.001, < 0.001, 0.017 and 0.041 for VBD vs LGLL, HTLVt, HTLVm; HTLVn; and MS, respectively.
+p = < 0.001 for HTLVm vs HTLVn or vs MS.